Delivery Order SPE2DE24D0013-SPE2D625F2JPM
- Not listed
- The U.S. Defense Department's Medical Supply Chain division awarded a $23,475.80 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The contract, designated XPCOV2/FLU/RSV-10, was awarded on July 29, 2025, with an ultimate completion date of August 12, 2025, and carries no set-aside designation. Work will be performed at Cepheid's Sunnyvale facility. This delivery order represents procurement of diagnostic testing...
- The U.S. Defense Department's Medical Supply Chain awarded Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, a firm fixed-price delivery order valued at $20,400 on August 11, 2025, with an ultimate completion date of August 18, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV)—infectious diseases commonly detected through Cepheid's GeneXpert molecular...
- The U.S. Defense Department's Medical Supply Chain awarded a $2,720 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 18, 2025, with an ultimate completion date of August 25, 2025. This delivery order, identified as XPCOV2/FLU/RSV-10, does not utilize a set-aside designation and represents a discrete procurement under one of Cepheid's existing indefinite delivery vehicles with the Department of Veterans...
- The U.S. Defense Department's Medical Supply Chain division awarded a $17,280 firm fixed-price delivery order to Cepheid Inc. on August 27, 2025, with an ultimate completion date of September 4, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus. Cepheid, a Sunnyvale, California-based manufacturer of advanced diagnostic systems and test kits, was selected without a set-aside...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $13,096.80 to Cepheid Inc. on July 28, 2025, for molecular diagnostic testing solutions. This firm fixed-price delivery order, designated 4568920464 and titled XPCOV2/FLU/RSV-10, carries an ultimate completion date of August 11, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. The contract involves diagnostic testing capabilities for COVID-19, influenza, and respiratory syncytial...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $2,040 to Cepheid Inc., a leading molecular diagnostics manufacturer based in Sunnyvale, California, on August 27, 2025. This firm fixed-price delivery order, designated 4569235830 and titled XPCOV2/FLU/RSV-10, is scheduled for completion by September 4, 2025, and carries no set-aside designation. The contract leverages Cepheid's expertise in advanced diagnostic systems and test kits, with the product...
- The Defense Department's Medical Supply Chain division awarded Cepheid Inc. a $17,952 firm fixed-price delivery order on August 4, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract is set to be completed by August 18, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. This delivery order represents a continuation of the Defense Department's reliance on Cepheid's GeneXpert...
- The U.S. Defense Medical Supply Chain awarded a $13.6K delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on September 2, 2025, with completion targeted for September 9, 2025. This firm fixed-price delivery order (Contract No. 4569302261) procures diagnostic testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract carries no set-aside designation and represents a continuation of...
- The Defense Department's Medical Supply Chain division awarded a $3,400 firm fixed-price delivery order to Cepheid Inc. on July 30, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, designated as delivery order XPCOV2/FLU/RSV-10, is scheduled for completion by August 6, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. This award carries no set-aside designation and represents a...
- Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,040 by the Defense Logistics Agency's Medical Supply Chain division on August 22, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by August 29, 2025, and covers molecular diagnostic testing solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award carries no set-aside...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F2JPMDelivery Order
The U.S. Defense Department's Medical Supply Chain awarded a $8,160 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, on September 2, 2025. This delivery order, designated 4569302270 for XPCOV2/FLU/RSV-10 testing solutions, is scheduled for completion by September 9, 2025, with work performed at the contractor's Sunnyvale facility. The award carries no small business set-aside designation and represents part of Cepheid's ongoing provision of diagnostic reagents and assays to federal healthcare systems. This delivery order likely draws from one of Cepheid's existing indefinite delivery vehicle contracts, most notably the $32.8 million single-award IDV with the VA's Veterans Integrated Service Network 6, which provides molecular diagnostic testing system reagents and assays through September 30, 2030. The contract supports PCR-based testing for infectious diseases including COVID-19, influenza, and respiratory syncytial virus (RSV), aligning with Cepheid's core competency in GeneXpert diagnostic systems and associated molecular test kits. The rapid completion timeline and relatively modest ceiling value suggest this delivery order addresses immediate operational needs for diagnostic supplies within the Defense Department's medical supply operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 9/2/25 |